Answers are grounded in this paper and cite their sources.
Case-control study examines outcomes of cocaine-associated ischemic stroke in patients, suggesting implications for prevention strategies.
Background and aims Stroke’s incidence among younger individuals is increasing, being substance use a growing cause. Cocaine has been identified as a risk factor for stroke. However, data on the clinical profile, acute management, and outcomes of cocaine-associated ischemic stroke in routine clinical practice remain limited; therefore, this study aims to address this gap. Methods We conducted a case–control study including consecutive patients with ischemic stroke who underwent urine cocaine testing at stroke onset at a comprehensive stroke center in Alicante between January 2023 and October 2025. Patients were classified as cocaine-positive or cocaine-negative based on toxicological screening. Results Among the 198 patients, 29 (14.64%) tested positive for cocaine. Age and sex distribution were similar between groups. Alcohol consumption (31.0% vs 6.5%, P < 0.001) and tobacco use (79.3% vs 45.6%, P = 0.006) were more frequent in cocaine-positive patients, whereas cannabis use was less common. Baseline mRS scores were lower in the cocaine-positive group (P = 0.003). Cardiovascular risk factors, cardioembolic disease, and prior chronic treatments did not differ significantly between groups. Acute stenting was more frequently required in cocaine-positive patients (33.3% vs 20.9%, P = 0.023). Baseline and discharge NIHSS scores, as well as 3-month functional outcomes, were comparable. Treatment-related complications did not differ significantly. Arterial dissection was more frequent among cocaine-positive patients (P = 0.022). At discharge, anticoagulation was more common in cocaine-negative patients, whereas antiplatelet therapy and statin use were more frequent in cocaine-positive patients (overall P = 0.009). Conclusions These findings highlight the importance of targeted prevention strategies, increased awareness, and health education to reduce substance-related stroke risk. Conflict of interest Nothing to disclose.
No takes yet. Share an insight, caveat, or question.
Pardo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: